US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Global X Genomics & Biotechnology ETF

65.12

-1.6500-2.47%

Volume:18.38K

Turnover:1.19M

Market Cap:92.78M

PE:- -

High:66.06

Open:66.06

Low:64.03

Close:66.77

52wk High:66.88

52wk Low:36.00

Shares:1.42M

Float Shares:1.42M

Volume Ratio:0.90

T/O Rate:1.29%

Dividend:0.65

Dividend Rate:0.99%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Twist Bioscience Director Robert Chess Disposes of Common Shares Worth $2.041.010,13

Illumina Building Clinical Momentum Amid Fading Competition, RBC Capital Markets Says

MT Newswires Live

Neurogene Advances Rett Gene Therapy Program and Extends Cash Runway to 2029

Illumina: Prices $300 Mln of 4.950% Senior Notes Due 2029 - SEC Filing

THOMSON REUTERS

Guardant Health Grants 46,044 RSUs to 149 New Employees Under Inducement Plan

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/GNOM/news?page=11"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GNOM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNOM\",,,,,undefined,":{"symbol":"GNOM","market":"US","secType":"STK","nameCN":"Global X Genomics & Biotechnology ETF","latestPrice":65.12,"timestamp":1787594188282,"preClose":66.77,"halted":0,"volume":18379,"delay":0,"changeRate":-0.024711696869851602,"floatShares":1424771,"shares":1424771,"eps":0,"marketStatus":"Trading","change":-1.65,"latestTime":"08-24 13:58:52 EDT","open":66.06,"high":66.06,"low":64.0301,"amount":1192868.96189,"amplitude":0.030401,"askPrice":65.2,"askSize":700,"bidPrice":64.85,"bidSize":20,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":66.77,"sharesOutstanding":1094672,"nav":66.56,"aum":94832765.15,"dividendRate":0.009946,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":66.06,"preClose":66.77,"latestTime":"09:29 EDT","volume":502,"amount":33166.99944,"timestamp":1787578199999,"change":-0.71,"changeRate":-0.010634,"amplitude":0.001647},"postHourTrading":{"tag":"盘后","latestPrice":65.99,"preClose":66.77,"latestTime":"19:30 EDT","volume":120,"amount":7931.95,"timestamp":1787355006727,"change":-0.78,"changeRate":-0.011682,"amplitude":0.011682},"volumeRatio":0.902659,"impliedVol":0.3308,"impliedVolPercentile":0.844},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNOM\",,,,,undefined,":{"symbol":"GNOM","floatShares":1424771,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.902659,"shares":1424771,"dividePrice":0.6477,"high":66.06,"amplitude":0.030401,"preClose":66.77,"low":64.0301,"week52Low":36,"pbRate":"--","week52High":66.88,"institutionHeld":0,"latestPrice":65.12,"committee":-0.944444,"eps":0,"divideRate":0.009946,"volume":18379,"delay":0,"ttmEps":0,"open":66.06,"prevYearClose":45.4562,"prevWeekClose":66.77,"prevMonthClose":54.17,"prevQuarterClose":56.834,"fiveDayClose":59.09,"twentyDayClose":53.6914,"sixtyDayClose":49.5125},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNOM\",params:#limit:5,,,undefined,":[{"date":"2026-06-29","symbol":"GNOM","amount":0.057885,"announcedDate":"2026-06-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-29","defaultRemindTime":1782739800000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-07","payableDate":"2026-06-29","currency":"USD","dateTimestamp":1782705600000,"payDate":"2026-07-07"},{"date":"2025-12-30","symbol":"GNOM","amount":0.591211,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-07","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-07"},{"market":"US","date":"2025-09-02","symbol":"GNOM","defaultRemindTime":1756819800000,"type":"split","dateTimestamp":1756785600000,"forFactor":4,"toFactor":1,"ratio":4},{"date":"2025-06-27","symbol":"GNOM","amount":0.00828,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-27","defaultRemindTime":1751031000000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-06-27","currency":"USD","dateTimestamp":1750996800000,"payDate":"2025-07-07"},{"market":"US","date":"2021-12-30","symbol":"GNOM","amount":0.006507,"defaultRemindTime":1640874600000,"name":"Global X Genomics & Biotechnology ETF","recordDate":"2022-01-07","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNOM\",market:\"US\",,,undefined,":[{"executeDate":"2020-12-30","recordDate":"2020-12-31","paymentDate":"2021-01-08","value":0.032402,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.006507,"currency":"USD"},{"executeDate":"2025-06-27","recordDate":"2025-06-27","paymentDate":"2025-07-07","value":0.00828,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-07","value":0.591211,"currency":"USD"},{"executeDate":"2026-06-29","recordDate":"2026-06-29","paymentDate":"2026-07-07","value":0.057885,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNOM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GNOM\",pageSize:20,pageCount:11,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658419948","title":"Twist Bioscience Director Robert Chess Disposes of Common Shares Worth $2.041.010,13","url":"https://stock-news.laohu8.com/highlight/detail?id=2658419948","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658419948?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:06","pubTimestamp":1786478789,"startTime":"0","endTime":"0","summary":"Twist Bioscience Director Robert Chess disposes of common shares worth $2.041.010,13Direktur Robert Chess mengeksekusi opsi, memperoleh 18.417 saham Twist Bioscience pada harga USD 11,89 per saham.Pad","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL7QKKdC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Twist Bioscience Director Robert Chess Disposes of Common Shares Worth $2.041.010,13","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDNA","BK4588","GNOM","BK4139","IDNA","ARKG","TWST","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658197479","title":"Illumina Building Clinical Momentum Amid Fading Competition, RBC Capital Markets Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658197479","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658197479?lang=en_us&edition=fundamental","pubTime":"2026-08-11 22:58","pubTimestamp":1786460297,"startTime":"0","endTime":"0","summary":"Illumina  is building clinical momentum as competitive concerns surrounding the company are fading, RBC Capital Markets said in a note Monday.The company's clinical sequencing revenue could grow at a durable mid-teens rate, driven by volume growth in oncology and easing pricing headwinds, according to the note.RBC said that while customers are expected to evaluate competitive sequencing instruments, Illumina will likely retain its clinical market share.Sequencing instrument sales could decline double digits in 2027 as they face more headwinds than previously expected, but clinical sequencing and sequencing services could offset this decline, the firm added.RBC Capital Markets has an outperform rating and a $230 price target on the stock.Price: 191.86, Change: +0.07, Percent Change: +0.04","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0310800379.SGD","BK4535","LU0029874061.USD","LU0128525929.USD","LU0128526141.USD","BK4548","BK4207","GSIB","BK4121","BK4585","GNOM","LU0708994859.HKD","LU0029864427.USD","BK4534","LU1267930573.SGD","BK4588","ILMN","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658657916","title":"Neurogene Advances Rett Gene Therapy Program and Extends Cash Runway to 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2658657916","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658657916?lang=en_us&edition=fundamental","pubTime":"2026-08-11 22:01","pubTimestamp":1786456868,"startTime":"0","endTime":"0","summary":"Neurogene ( ($NGNE) ) just unveiled an announcement. Neurogene reported strong progress in its NGN-401 gene therapy program for Rett syndrome, high...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurogene-advances-rett-gene-therapy-program-and-extends-cash-runway-to-2029?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurogene-advances-rett-gene-therapy-program-and-extends-cash-runway-to-2029?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","SYNB","LFSC","CNCR","GNOM","TBXU","FBT","BK4588","IBBQ","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658545739","title":"Illumina: Prices $300 Mln of 4.950% Senior Notes Due 2029 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2658545739","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658545739?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:59","pubTimestamp":1786395574,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471NB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GNOM","LU0128526141.USD","BK4535","BK4534","ILMN","LU0029874061.USD","GNMX","BK4585","BK4121","BK4548","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658599689","title":"Guardant Health Grants 46,044 RSUs to 149 New Employees Under Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2658599689","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658599689?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:13","pubTimestamp":1786392812,"startTime":"0","endTime":"0","summary":"Guardant Health grants 46,044 RSUs to 149 new employees under inducement planGuardant Health set inducement RSU grants covering 46,044 common shares for 149 new non-executive hires, with an Aug. 3, 20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL208d3j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","GNOM","GDOC","BK4535","BK4551","LU0320765992.SGD","PTH","EKG","GH","BK4196","GNMX","LU0109394709.USD","BK4585","LU0889565916.HKD","HELX","FFOX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":11,"totalSize":205,"code":"91000000","status":"200"}]}}